Life MD Financial Results

Rapid growth in profitability after achieving adjusted EBITDA profit in Q4 '22 Annual consolidated adjusted EBITDA ($ millions) $20M $12M 2023A 2024E $(15)M ($38)M 2022A 2021A Note: Consolidated adjusted EBITDA includes Telehealth and WorkSimpli results. 2024 Forecast is based on the midpoint of the 2024 guidance range of $18 million to $22 million for Adjusted EBITDA 16 Life MD*

View entire presentation